Cochrane Abstracts
Cernilton for benign prostatic hyperplasia: Cochrane systematic review
Cernilton for benign prostatic hyperplasia: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cernilton for Benign Prostatic Hyperplasia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438938/all/Cernilton_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review. Accessed 30 January 2023.
Cernilton for benign prostatic hyperplasia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438938/all/Cernilton_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review. Accessed January 30, 2023.
Cernilton for benign prostatic hyperplasia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438938/all/Cernilton_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review
Cernilton for Benign Prostatic Hyperplasia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 January 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438938/all/Cernilton_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cernilton for benign prostatic hyperplasia: Cochrane systematic review
ID - 438938
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438938/all/Cernilton_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
